Bruker Corp. (NASDAQ:BRKR)

CAPS Rating: 3 out of 5

The Company designs, manufactures, services and markets analytical and life science systems and associated products to address the needs of its customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research.

Recs

0
Player Avatar Alisadrew (< 20) Submitted: 5/10/2008 7:47:02 AM : Outperform Start Price: $11.95 BRKR Score: +28.15

Biotech stock punished for missing 1st Q 2008 earnings will rebound in the next Q and beyond.
Solid fundamentals.

Featured Broker Partners


Advertisement